SMTL ID : 4d0s.1

Mtb InhA complex with Pyradizinone compound 14

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.64 Å

Oligo State

homo-tetramer

Ligands

4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)

NAD.1: 23 residues within 4Å: Chain A: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, K.165, A.191, G.192, P.193, I.194, T.196 Ligands: 9G4.2 20 PLIP interactions: 20 interactions with chain A Hydrophobic interactions: A:I.21, A:F.149, A:A.191 Hydrogen bonds: A:G.14, A:S.20, A:I.21, A:D.64, A:D.64, A:V.65, A:I.95, A:G.96, A:K.165, A:I.194, A:I.194, A:T.196 Water bridges: A:G.14, A:A.22, A:F.41, A:F.41, A:I.95 NAD.4: 23 residues within 4Å: Chain B: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, K.165, A.191, G.192, P.193, I.194, T.196 Ligands: 9G4.5 21 PLIP interactions: 21 interactions with chain B Hydrophobic interactions: B:I.21, B:F.149, B:A.191 Hydrogen bonds: B:G.14, B:S.20, B:I.21, B:D.64, B:V.65, B:I.95, B:G.96, B:K.165, B:I.194, B:I.194, B:T.196, B:T.196 Water bridges: B:G.14, B:A.22, B:F.41, B:F.41, B:F.41, B:I.95 NAD.6: 23 residues within 4Å: Chain C: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, K.165, A.191, G.192, P.193, I.194, T.196 Ligands: 9G4.7 20 PLIP interactions: 20 interactions with chain C Hydrophobic interactions: C:I.21, C:F.149, C:A.191 Hydrogen bonds: C:G.14, C:I.21, C:D.64, C:D.64, C:V.65, C:I.95, C:G.96, C:K.165, C:I.194, C:I.194 Water bridges: C:A.22, C:F.41, C:F.41, C:F.41, C:I.95, C:T.196 pi-Stacking: C:F.41 NAD.8: 23 residues within 4Å: Chain D: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, K.165, A.191, G.192, P.193, I.194, T.196 Ligands: 9G4.9 20 PLIP interactions: 20 interactions with chain D Hydrophobic interactions: D:I.21, D:F.149, D:A.191 Hydrogen bonds: D:G.14, D:S.20, D:I.21, D:D.64, D:V.65, D:I.95, D:G.96, D:K.165, D:I.194, D:I.194, D:T.196 Water bridges: D:G.14, D:A.22, D:F.41, D:I.95, D:T.196 pi-Stacking: D:F.41

4 x 9G4: 1-{4-[(acetylamino)methyl]phenyl}-4-(4-chlorophenoxy)-6-oxo-1,6-dihydropyridazine-3-carboxamide(Non-covalent)

9G4.2: 15 residues within 4Å: Chain A: G.96, F.97, M.98, M.103, F.149, D.150, M.155, Y.158, M.161, A.191, G.192, P.193, I.194, W.222 Ligands: NAD.1 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:F.149, A:F.149, A:W.222 Hydrogen bonds: A:M.98, A:Y.158, A:I.194, A:I.194 pi-Stacking: A:F.149, A:Y.158 Halogen bonds: A:D.150 9G4.5: 15 residues within 4Å: Chain B: G.96, F.97, M.98, M.103, F.149, D.150, M.155, Y.158, M.161, A.191, G.192, P.193, I.194, W.222 Ligands: NAD.4 10 PLIP interactions: 10 interactions with chain B Hydrophobic interactions: B:F.149, B:F.149, B:P.193, B:W.222 Hydrogen bonds: B:M.98, B:I.194, B:I.194 pi-Stacking: B:F.149, B:Y.158 Halogen bonds: B:D.150 9G4.7: 16 residues within 4Å: Chain C: G.96, F.97, M.98, M.103, F.149, D.150, M.155, Y.158, M.161, A.191, G.192, P.193, I.194, L.218, W.222 Ligands: NAD.6 12 PLIP interactions: 12 interactions with chain C Hydrophobic interactions: C:F.97, C:F.149, C:F.149, C:P.193, C:L.218, C:W.222 Hydrogen bonds: C:M.98, C:I.194, C:I.194 pi-Stacking: C:F.149, C:Y.158 Halogen bonds: C:D.150 9G4.9: 15 residues within 4Å: Chain D: G.96, F.97, M.98, M.103, F.149, D.150, M.155, Y.158, M.161, A.191, G.192, P.193, I.194, W.222 Ligands: NAD.8 10 PLIP interactions: 10 interactions with chain D Hydrophobic interactions: D:F.149, D:F.149, D:P.193, D:W.222 Hydrogen bonds: D:M.98, D:Y.158, D:I.194 pi-Stacking: D:F.149, D:Y.158 Halogen bonds: D:D.150

2 x MG: MAGNESIUM ION(Non-covalent)

MG.3: 3 residues within 4Å: Chain A: D.223, Q.224, A.226 5 PLIP interactions: 3 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:D.223, A:Q.224, A:A.226, H2O.8, H2O.8 MG.10: 3 residues within 4Å: Chain D: D.223, Q.224, A.226 5 PLIP interactions: 3 interactions with chain D, 2 Ligand-Water interactions Metal complexes: D:D.223, D:Q.224, D:A.226, H2O.33, H2O.33

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lange, S., Pyridazinones: A Novel Scaffold with Excellent Physicochemical Properties and Safety Profile for a Clinically Validated Target of Mycobacterium Tuberculosis. To be Published

Release Date

2015-05-20

Peptides

ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH]: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH]

Related Entries With Identical Sequence